NEW DELHI:The UN has expressed solidarity with India in its fight against coronavirus, with a top official at the world body’s health agency praising Prime Minister Narendra Modi’s 21-day nationwide lockdown as a “comprehensive and robust” response to the raging COVID-19 pandemic.
Globally, the death toll from the coronavirus has risen to 18,915 with more than 422,900 cases reported in over 165 countries and territories, according to data from Johns Hopkins University.
The number of coronavirus cases in India stood at 562 on Wednesday with 10 COVID-19 deaths reported so far, according to Health Ministry data.Active cases stand at 512. This includes 40 cured/discharged patients.
The Home Ministry on Wednesday clarified that the second death reported in Delhi was COVID-19 negative. Ten deaths so far have been reported from Maharashtra (two), Bihar, Karnataka, Gujarat, Punjab, Delhi, West Bengal, Tamil Nadu, and Himachal Pradesh. According to the data, the number of active COVID-19 cases stood at 512 while 41 people have been cured/discharged or migrated. The figure includes 43 foreign nationals, the Health Ministry said.
A 54-year-old man infected with coronavirus died at a hospital in Chennai in the early hours of Wednesday, the first death recorded in Tamil Nadu due to the contagion, state Health Minister C Vijayabaskar said.
In an attempt to stem the spread of coronavirus in India, Prime Minister Modi on Tuesday announced a nationwide lockdown for three weeks.
The exercise to update the National Population Register (NPR) and the first phase of the Census-2021 have been deferred indefinitely due to the 21-day lockdown.The two exercises were supposed to be carried out from 1 April to 30 September.
Maharashtra reported five new coronavirus cases since Tuesday night, taking the number of cases in the state to 112, the highest in the country so far, officials said.
The latest cases are from Sangli district, where five members of a family in Islampur tested coronavirus positive, the officials said on Wednesday.”We are checking if the five have a recent travel history within India or outside,” an official said.
The number of COVID-19 cases in Gujarat has gone up to 38 as three more people tested positive for the coronavirus on Wednesday, a health department official said.
Five persons admitted in different hospitals of Indore have tested positive for the coronavirus, taking the number of COVID-19 cases in Madhya Pradesh to 14, health officials said on Wednesday. None of the patients in Indore have a history of travel to abroad.
The five COVID-19 patients in Indore include a woman from neighbouring Ujjain while others are residents of Indore,Chief Medical and Health Officer Dr Anusuya Gawli said.
A 33-year-old resident of Pilibhit has been tested positive for coronavirus on Wednesday. “He doesn’t have any travel history, it is a confirmed case of contact transmission,” Dr Sudhir Singh, King George’s Medical University, Lucknow said.
A batch of 277 people evacuated from the coronavirus-hit Iran arrived at the Jodhpur airport in Rajasthan on Wednesday early morning, a defence spokesperson said. He said preliminary screening of the evacuees, mostly pilgrims, was conducted at the airport upon arrival and thereafter they were taken to the Army Wellness Facility set up at the Jodhpur Military Station.
They were flown in from Iran, which has been severely affected by the deadly infection. The Army, in coordination with the Rajasthan state medical authorities and civil administration, has made adequate medical and administrative arrangements to ensure a comfortable stay for the evacuees and provide prophylactic medical support, he said.
Prime Minister Narendra Modi extended this wishes on Wednesday which marked New Year celebrations in various states across India. He noted in view of the current situation in the country which is fighting against the coronavirus outbreak, the celebrations “might not be the same this year.”
The government on Wednesday banned export of anti-malarial drug hydroxycloroquine, with immediate effect to ensure sufficient availability of the medicine in the domestic market.